These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2874066)

  • 21. [Serous and mucinous ovarian cystadenomas at the limit of malignancy].
    Chenevart P; Gloor E
    Schweiz Med Wochenschr; 1980 Apr; 110(14):531-9. PubMed ID: 7375903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cystic tumors of the pancreas: dynamic CT studies.
    Soyer P; Rabenandrasana A; Van Beers B; Barge J; Sibert A; Laissy JP; Achour E; Levesque M
    J Comput Assist Tomogr; 1994; 18(3):420-6. PubMed ID: 8188910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Histopathology of the ovarian tumors derived from the Müllerian (paramesonephric) epithelium and their differential diagnosis. I. Adenofibroma. Serous and mucinous cystadenomas and cystadenocarcinomas (author's transl)].
    Jirásek JE
    Cesk Gynekol; 1973 Nov; 38(9):705-8. PubMed ID: 4765179
    [No Abstract]   [Full Text] [Related]  

  • 24. Common epithelial tumors of borderline malignancy (carcinomas of low malignant potential).
    Scully RE
    Bull Cancer; 1982; 69(3):228-38. PubMed ID: 6289947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ras oncogene product p21 expression and prognosis of human ovarian tumors.
    Yaginuma Y; Yamashita K; Kuzumaki N; Fujita M; Shimizu T
    Gynecol Oncol; 1992 Jul; 46(1):45-50. PubMed ID: 1634140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear findings of ovarian surface epithelial tumors.
    Hirokawa M; Miyake Y; Shimizu M; Kanahara T; Manabe T; Fujiwara K; Kohno I
    Diagn Cytopathol; 2000 Jan; 22(1):27-9. PubMed ID: 10613969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demonstration of neuroendocrine cells in ovarian mucinous tumors.
    Sasaki E; Sasano N; Kimura N; Andoh N; Yajima A
    Int J Gynecol Pathol; 1989; 8(3):189-200. PubMed ID: 2570045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p63 expression in epithelial ovarian tumors.
    Poli Neto OB; Candido Dos Reis FJ; Zambelli Ramalho LN; Nogueira AA; de Andrade JM
    Int J Gynecol Cancer; 2006; 16(1):152-5. PubMed ID: 16445626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystic tumors of the pancreas. New clinical, radiologic, and pathologic observations in 67 patients.
    Warshaw AL; Compton CC; Lewandrowski K; Cardenosa G; Mueller PR
    Ann Surg; 1990 Oct; 212(4):432-43; discussion 444-5. PubMed ID: 2171441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stage-specific embryonic antigen 4 expression in epithelial ovarian carcinoma.
    Ye F; Li Y; Hu Y; Zhou C; Hu Y; Chen H
    Int J Gynecol Cancer; 2010 Aug; 20(6):958-64. PubMed ID: 20683402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of borderline ovarian tumors.
    Tîrnovanu MC; Amancei S; Dumitrescu A; Onofriescu M; Dumitraşcu I
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1069-75. PubMed ID: 23700890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of Lysine-specific demethylase 1 in human epithelial ovarian cancer.
    Chen C; Ge J; Lu Q; Ping G; Yang C; Fang X
    J Ovarian Res; 2015 May; 8():28. PubMed ID: 25956476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathology of mucinous ovarian cystadenomas. I. Argyrophil and argentaffin cells and epithelial mucosubstances.
    Klemi PJ
    Acta Pathol Microbiol Scand A; 1978 Nov; 86A(6):465-70. PubMed ID: 716907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis in patients with serous and mucinous stage I borderline ovarian tumors.
    Song T; Lee YY; Choi CH; Kim TJ; Lee JW; Kim BG; Bae DS
    Int J Gynecol Cancer; 2012 Jun; 22(5):770-7. PubMed ID: 22426410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma.
    Lewandrowski KB; Southern JF; Pins MR; Compton CC; Warshaw AL
    Ann Surg; 1993 Jan; 217(1):41-7. PubMed ID: 8424699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK; Soslow RA; Longacre TA
    Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relationship between malignant transformation of ovarian mucinous cystadenoma and intestinal epithelial metaplasia].
    Zhong CQ
    Zhonghua Bing Li Xue Za Zhi; 1989 Jun; 18(2):134-6. PubMed ID: 2555075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and mutational analysis of c-kit in ovarian surface epithelial tumors.
    Kim DJ; Lee MH; Park TI; Bae HI
    J Korean Med Sci; 2006 Feb; 21(1):81-5. PubMed ID: 16479070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of c-myc and mutation of the KRAS gene in patients with ovarian mucinous tumors.
    Li XS; Sun J; He XL
    Genet Mol Res; 2015 Sep; 14(3):10752-9. PubMed ID: 26400304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucinous tumors of the ovary. II. Ultrastructural features of mucinous cystadenocarcinomas.
    Fenoglio CM; Ferenczy A; Richart RM
    Am J Obstet Gynecol; 1976 Aug; 125(7):990-9. PubMed ID: 941955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.